Abdel-Razeq H - Search Results

1

The prognostic utility of ¹⁸F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis.

Al-Ibraheem A, Abdlkadir AS, Al-Adhami DA, Sathekge M, Bom HH, Ma'koseh M, Mansour A, Abdel-Razeq H, Al-Rabi K, Estrada-Lobato E, Al-Hussaini M, Matalka I, Abdel Rahman Z, Fanti S. Al-Ibraheem A, et al. Among authors: abdel razeq h. Front Immunol. 2024 Sep 2;15:1424269. doi: 10.3389/fimmu.2024.1424269. eCollection 2024. Front Immunol. 2024. PMID: 39286245 Free PMC article.

2

Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly.

Al-Hilali A, Wulff K, Abdel-Razeq H, Saud KA, Al-Gaili F, Herrmann FH. Al-Hilali A, et al. Thromb Haemost. 2007 Apr;97(4):542-5. Thromb Haemost. 2007. PMID: 17393015

3

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.

Gerotziafas GT, Taher A, Abdel-Razeq H, AboElnazar E, Spyropoulos AC, El Shemmari S, Larsen AK, Elalamy I; COMPASS–CAT Working Group. Gerotziafas GT, et al. Oncologist. 2017 Oct;22(10):1222-1231. doi: 10.1634/theoncologist.2016-0414. Epub 2017 May 26. Oncologist. 2017. PMID: 28550032 Free PMC article.

4

Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need.

Brenner B, Ay C, Gal GL, Carrier M, Muñoz AJ, Agnelli G, Rocha ATC, Abdel-Razeq H, Elalamy I, Falanga A. Brenner B, et al. Thromb Update. 2022 Mar;6:100098. doi: 10.1016/j.tru.2022.100098. Epub 2022 Jan 10. Thromb Update. 2022. PMID: 38620707 Free PMC article. Review.

5

Venous thromboembolism (VTE) in hospitalized cancer patients: prophylaxis failure or failure to prophylax!

Abdel-Razeq H, Albadainah F, Hijjawi S, Mansour A, Treish I. Abdel-Razeq H, et al. J Thromb Thrombolysis. 2011 Jan;31(1):107-12. doi: 10.1007/s11239-010-0509-x. J Thromb Thrombolysis. 2011. PMID: 20686822

6

Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome--a comprehensive cancer center experience.

Abdel-Razeq HN, Mansour AH, Ismael YM. Abdel-Razeq HN, et al. Vasc Health Risk Manag. 2011;7:153-8. doi: 10.2147/VHRM.S17947. Epub 2011 Mar 15. Vasc Health Risk Manag. 2011. PMID: 21468175 Free PMC article.

7

The application of clinical variables and models to predict pulmonary embolism in cancer patients: a comprehensive single cancer center experience.

Mansour A, Ismael Y, Abunasser M, Hammode E, Turfa R, Abdel-Razeq H. Mansour A, et al. Patient Prefer Adherence. 2013 Oct 23;7:1111-6. doi: 10.2147/PPA.S46372. eCollection 2013. Patient Prefer Adherence. 2013. PMID: 24187488 Free PMC article.

8

Inferior vena cava filters in patients with advanced-stage cancer.

Mansour A, Ismael Y, Abdel-Razeq H. Mansour A, et al. Hematol Oncol Stem Cell Ther. 2014 Dec;7(4):136-41. doi: 10.1016/j.hemonc.2014.09.005. Epub 2014 Oct 6. Hematol Oncol Stem Cell Ther. 2014. PMID: 25300564 Free article.

9

MR imaging features of intracranial primary CNS lymphoma in immune competent patients.

Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HA. Mansour A, et al. Cancer Imaging. 2014 May 7;14(1):22. doi: 10.1186/1470-7330-14-22. Cancer Imaging. 2014. PMID: 25608570 Free PMC article.

10

Cancer care in Jordan.

Abdel-Razeq H, Attiga F, Mansour A. Abdel-Razeq H, et al. Hematol Oncol Stem Cell Ther. 2015 Jun;8(2):64-70. doi: 10.1016/j.hemonc.2015.02.001. Epub 2015 Feb 21. Hematol Oncol Stem Cell Ther. 2015. PMID: 25732671 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters